Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Catecholamines and obesity: effects of exercise and training.

Tytuł:
Catecholamines and obesity: effects of exercise and training.
Autorzy:
Zouhal H; Movement, Sport Sciences and Health Laboratory, UFR-APS, Université Rennes 2-ENS-Cachan, Avenue Charles Tillon, CS 24414, 35044 Rennes Cedex, France. />Lemoine-Morel S
Mathieu ME
Casazza GA
Jabbour G
Źródło:
Sports medicine (Auckland, N.Z.) [Sports Med] 2013 Jul; Vol. 43 (7), pp. 591-600.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Publication: Auckland : Adis, Springer International
Original Publication: [Auckland, N.Z. ; Newtown, PA] : ADIS,
MeSH Terms:
Catecholamines/*blood
Exercise/*physiology
Obesity/*physiopathology
Adrenal Glands/metabolism ; Adrenal Glands/physiopathology ; Biomarkers/blood ; Humans ; Obesity/blood ; Sympathetic Nervous System/metabolism ; Sympathetic Nervous System/physiopathology
References:
J Clin Endocrinol Metab. 2012 Feb;97(2):605-13. (PMID: 22090279)
Eur J Appl Physiol. 2010 Sep;110(2):247-54. (PMID: 20454801)
Hypertension. 2007 Jan;49(1):27-33. (PMID: 17116758)
N Engl J Med. 1988 Feb 25;318(8):467-72. (PMID: 3340128)
Am J Physiol Endocrinol Metab. 2003 Nov;285(5):E984-90. (PMID: 14534074)
Obesity (Silver Spring). 2007 Sep;15(9):2256-62. (PMID: 17890494)
Nephrol Ther. 2011 Apr;7(2):69-79. (PMID: 21156355)
J Lipid Res. 1991 Oct;32(10):1625-33. (PMID: 1797943)
Obesity (Silver Spring). 2009 Jan;17(1):72-7. (PMID: 18997672)
J Appl Physiol (1985). 2002 Mar;92(3):1300-9. (PMID: 11842071)
FASEB J. 2004 May;18(7):908-10. (PMID: 15033935)
J Anat. 1993 Oct;183 ( Pt 2):277-89. (PMID: 7507911)
Am J Physiol. 1998 Dec;275(6):E951-6. (PMID: 9843736)
Int J Sports Med. 2013 Aug;34(8):742-7. (PMID: 23444090)
Clin Endocrinol (Oxf). 1996 Dec;45(6):769-73. (PMID: 9039344)
J Clin Endocrinol Metab. 1982 Apr;54(4):785-92. (PMID: 7037815)
Int J Obes. 1987;11(2):141-9. (PMID: 3610467)
Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S89-91. (PMID: 10997618)
Med Sci Sports Exerc. 2002 May;34(5):806-13. (PMID: 11984299)
Diabetes. 2009 May;58(5):1126-32. (PMID: 19188428)
Physiol Rev. 1979 Oct;59(4):919-57. (PMID: 227005)
Trends Pharmacol Sci. 2003 Jun;24(6):276-83. (PMID: 12823953)
Am J Physiol. 1997 Feb;272(2 Pt 1):E248-54. (PMID: 9124331)
Am J Physiol. 1997 Jul;273(1 Pt 1):E149-55. (PMID: 9252491)
Metabolism. 1979 Dec;28(12):1198-205. (PMID: 229383)
Am J Physiol. 1948 Jun;153(3):586-600. (PMID: 18882199)
Psychosom Med. 1990 Jan-Feb;52(1):97-108. (PMID: 2305026)
Metabolism. 2000 May;49(5):579-87. (PMID: 10831166)
Prog Lipid Res. 2009 Sep;48(5):275-97. (PMID: 19464318)
Metabolism. 2008 May;57(5):708-11. (PMID: 18442637)
Obes Res. 1997 Jul;5(4):341-7. (PMID: 9285842)
Int J Obes Relat Metab Disord. 1999 Apr;23(4):374-81. (PMID: 10340815)
Sports Med. 2008;38(5):401-23. (PMID: 18416594)
Am J Physiol. 1997 Sep;273(3 Pt 1):E497-506. (PMID: 9316438)
Mol Cell Endocrinol. 2010 Apr 29;318(1-2):34-43. (PMID: 19747957)
Circulation. 1997 Nov 18;96(10):3423-9. (PMID: 9396437)
Metabolism. 1994 May;43(5):621-5. (PMID: 8177051)
Acta Paediatr. 2003;92(3):283-90. (PMID: 12725541)
J Clin Endocrinol Metab. 2011 Mar;96(3):E503-8. (PMID: 21177786)
Eur J Appl Physiol Occup Physiol. 1982;49(3):389-99. (PMID: 6754371)
Am J Clin Nutr. 2008 Jun;87(6):1596-601. (PMID: 18541545)
Scand J Work Environ Health. 2000 Aug;26(4):306-16. (PMID: 10994796)
J Clin Endocrinol Metab. 2005 Nov;90(11):5998-6005. (PMID: 16091482)
J Hypertens. 2010 Jun;28(6):1313-20. (PMID: 20164804)
Diabetologia. 2008 Feb;51(2):320-7. (PMID: 18060661)
Eur J Appl Physiol. 2006 May;97(1):68-75. (PMID: 16477445)
J Appl Physiol (1985). 1991 Feb;70(2):882-8. (PMID: 2022581)
J Clin Invest. 1987 Jan;79(1):207-13. (PMID: 3540009)
Obes Res. 2003 Feb;11(2):247-56. (PMID: 12582221)
Med Sci Sports Exerc. 2011 Mar;43(3):408-15. (PMID: 20689461)
Diabetologia. 2005 Dec;48(12):2631-40. (PMID: 16273345)
Hypertension. 1991 May;17(5):669-77. (PMID: 2022410)
J Hypertens. 2010 Mar;28(3):543-50. (PMID: 20139772)
Am J Physiol. 1997 Jun;272(6 Pt 1):E976-80. (PMID: 9227440)
Eur J Epidemiol. 2008;23(4):303-10. (PMID: 18322807)
Psychosom Med. 2008 Sep;70(7):797-804. (PMID: 18725427)
J Clin Invest. 1997 Jun 1;99(11):2568-73. (PMID: 9169485)
J Clin Endocrinol Metab. 2002 Mar;87(3):1274-81. (PMID: 11889199)
Physiol Rev. 1985 Jan;65(1):149-209. (PMID: 3880897)
Eur J Appl Physiol Occup Physiol. 1992;65(4):354-9. (PMID: 1425636)
Acta Diabetol. 1997 Aug;34(2):61-6. (PMID: 9325466)
Baillieres Clin Endocrinol Metab. 1987 May;1(2):279-98. (PMID: 3327495)
Obes Rev. 2000 May;1(1):5-15. (PMID: 12119646)
Psychoneuroendocrinology. 2005 Nov;30(10):1017-21. (PMID: 15963652)
J Clin Invest. 1993 Oct;92(4):1730-5. (PMID: 8408625)
J Hypertens. 2004 Dec;22(12):2363-9. (PMID: 15614031)
Circulation. 2002 Nov 12;106(20):2533-6. (PMID: 12427647)
Int J Sports Physiol Perform. 2013 Jul;8(4):358-65. (PMID: 23113934)
Eur J Nutr. 2003 Aug;42(4):181-7. (PMID: 12923648)
Metabolism. 2005 Apr;54(4):430-8. (PMID: 15798947)
Niger J Clin Pract. 2011 Oct-Dec;14(4):390-4. (PMID: 22248935)
J Clin Endocrinol Metab. 1989 Feb;68(2):438-45. (PMID: 2645309)
J Clin Endocrinol Metab. 1994 Jun;78(6):1331-5. (PMID: 8200934)
Br J Pharmacol. 1996 Mar;117(5):907-13. (PMID: 8851509)
Metabolism. 1984 Mar;33(3):235-9. (PMID: 6694563)
Eur J Clin Invest. 1985 Feb;15(1):30-7. (PMID: 2859198)
Exp Physiol. 2005 Sep;90(5):673-82. (PMID: 16105936)
Diabetes Care. 1993 Jan;16(1):232-8. (PMID: 8422781)
Obes Res. 2001 Feb;9(2):78-85. (PMID: 11316350)
Am J Physiol. 1999 Oct;277(4):R1076-83. (PMID: 10516247)
J Clin Endocrinol Metab. 1993 Aug;77(2):352-5. (PMID: 8393882)
Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H414-8. (PMID: 14988078)
Physiol Behav. 2007 Jan 30;90(1):66-72. (PMID: 17023010)
Arch Intern Med. 1998 Dec 7-21;158(22):2477-83. (PMID: 9855386)
Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S8-17. (PMID: 10997600)
Trends Endocrinol Metab. 2003 Oct;14(8):386-92. (PMID: 14516937)
J Clin Invest. 1995 Mar;95(3):1109-16. (PMID: 7883959)
J Clin Endocrinol Metab. 2004 Mar;89(3):1325-31. (PMID: 15001629)
Int J Obes Relat Metab Disord. 2002 Oct;26(10):1373-8. (PMID: 12355334)
Int J Sports Med. 1998 Apr;19(3):172-6. (PMID: 9630021)
Hypertension. 2007 Nov;50(5):862-8. (PMID: 17909120)
Biochem Biophys Res Commun. 1981 Aug 31;101(4):1186-92. (PMID: 6272775)
Am J Physiol Regul Integr Comp Physiol. 2000 Aug;279(2):R499-504. (PMID: 10938238)
Eur J Appl Physiol Occup Physiol. 1985;53(4):308-11. (PMID: 2985381)
Metabolism. 1990 Apr;39(4):410-7. (PMID: 2182975)
Ann N Y Acad Sci. 2006 Nov;1083:129-52. (PMID: 17148737)
J Appl Physiol (1985). 2006 May;100(5):1630-7. (PMID: 16373448)
Eur J Clin Invest. 1987 Apr;17(2):156-65. (PMID: 3034620)
Eur J Clin Invest. 1985 Dec;15(6):341-8. (PMID: 3007159)
Am J Physiol. 1991 Apr;260(4 Pt 2):R785-91. (PMID: 2012249)
Substance Nomenclature:
0 (Biomarkers)
0 (Catecholamines)
Entry Date(s):
Date Created: 20130425 Date Completed: 20140220 Latest Revision: 20220316
Update Code:
20240104
DOI:
10.1007/s40279-013-0039-8
PMID:
23613311
Czasopismo naukowe
Excess body fat in obese individuals can affect the catecholamine response to various stimuli. Indeed, several studies report lower plasma catecholamine concentrations in obese subjects compared with nonobese subjects in response to submaximal or maximal exercise. This low catecholamine response reflects decreased sympathetic nervous system (SNS) activity. Although the relationship between the SNS and obesity is not well established, some authors have suggested that low SNS activity may contribute to the development of obesity. A decreased catecholamine response could affect α- and β-adrenoceptor sensitivity in adipose tissue, reducing lipolysis and increasing fat stores. Few studies have examined the effects of obesity on the plasma catecholamine response at rest and during exercise in adolescents. It is interesting to note that the effects of age, sex, and degree of obesity and the impact of very intense exercise on the catecholamine response have not yet been well examined. Moreover, the hormonal concentrations measured in the majority of obesity studies did not take into account plasma volume changes. This methodological factor can also undoubtedly influence plasma catecholamine results.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies